← FDA Drug Approvals (Drugs@FDA)
LINAGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUNSHINE · Approved 2021-08-31
Drug application
- FDA Application #
ANDA208335- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINAGLIPTIN
- Generic name
- Linagliptin
- Active ingredients
- LINAGLIPTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SUNSHINE
- First approval
- 2021-08-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown